3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
3
Melanoma
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Various Advanced Cancer
1
Uveal Melanoma
1
Urothelial Cancer
1
Stomach Neoplasms
1
Microsatellite Unstable Colorectal Cancer
1
Mesothelioma
1
Colorectal Neoplasms
1
Advanced or Metastatic Solid Tumors
1
Adenocarcinoma Of Esophagus
1
Interventions
relatlimab
1
daratumumab
1
cobimetinib
1
Nivolumab
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Microsatellite Unstable Colorectal Cancer
×
Ipilimumab
×
Clear all
NCT02060188
2025-11-06
CheckMate142
Bristol-Myers Squibb
Phase 2
Completed
385 enrolled
17 charts
2 FDA